Revance Therapeutics, Inc. Announces Participation in Cowen 34th Annual Health Care Conference

NEWARK, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), today announced that its management is scheduled to participate in the Cowen 34th Annual Health Care Conference in Boston.

Revance management is scheduled to present on Wednesday, March 5, 2014 at 9:20 am ET. Interested parties can access the live audio webcast for this conference presentation at www.revance.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.

About Revance Therapeutics, Inc.

Revance Therapeutics, Inc. (Revance) is a specialty biopharmaceutical company which develops botulinum toxin products for use in aesthetic and therapeutic indications. Revance has developed a platform technology, TransMTS®, that enables local, targeted delivery of botulinum toxin and other potent macromolecules across skin without patches, needles or other invasive procedures.

CONTACT: Westwicke Partners Ana Petrovic (415) 513-1281 ana.petrovic@westwicke.comSource:Revance Therapeutics, Inc.